A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

Some people believe chatbots like ChatGPT can provide an affordable alternative to in-person psychedelic-assisted therapy.

None have been approved by the Food and Drug Administration so far, though in 2019, Johnson & Johnson received FDA permission ...

Psychedelics as an adjunctive therapy to psychiatric counseling may be feasible for anxiety and mood disorders, but proper ...

An interview with Rev. Hunt Priest, who said “Why do we imagine that God is not still working through our visions, dreams, ...

According to atai Life Sciences, a single dose of an investigational intranasal formulation of mebufotenin benzoate, a ...

The head of the U.S. Department of Veterans Affairs (VA) says he’s “particularly proud” of the administration’s work to ...

Beacon Hill Roll Call records local representatives’ and senators’ votes on roll calls from the week of June 30-July 4.

The 2017 show marked the first time Kidman worked with series creator David E. Kelley, leading to a longstanding professional ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

A recent study asks whether altering consciousness with psychoactive substances can have religious value. Americans take ...